Skip to main content

Animations

Matthew Peck

Cambridge, Massachusetts

Matthew Peck Profile

Matt is Co-Founder and COO of Cambridge, Massachusetts based DaCapo Brainscience, a biotechnology company whose mission is to develop some of the first disease-modifying therapies for neurodegenerative diseases.

Matt is Co-Founder and COO of Cambridge, Massachusetts based DaCapo Brainscience, a biotechnology company whose mission is to develop some of the first disease-modifying therapies for neurodegenerative diseases. To do this DaCapo combines novel techniques, developed by its scientific founders in neuroscience, machine learning, and stem-cell technologies, to identify and validate new targets and new categories of disease within the larger CNS universe.

Before co-founding DaCapo, Matt worked at Caxton Associates between 2007 and 2019, where he was promoted to Partner in January 2013. Matt ran at its peak a $1 billion macro-oriented portfolio that focused primarily on emerging markets credit, rates, foreign exchange, and equities. Before that Matt worked at Citigroup in several roles, including that of a #1 rated Institutional Investor analyst. Matt started his career at Salomon Brothers in 1994. Matt is a 1994 graduate of Dartmouth College where he double majored in economics and government. Matt was born in Belmont, Massachusetts and is a 1990 graduate of the Belmont Hill School.

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.